Chronic Administration of Lithium or Other Antidepressants Increases Levels of DARPP-32 in Rat Frontal Cortex
- 1 September 1992
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 59 (3) , 1164-1167
- https://doi.org/10.1111/j.1471-4159.1992.tb08361.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme.Proceedings of the National Academy of Sciences, 1991
- Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex.Proceedings of the National Academy of Sciences, 1991
- Identification of a dopamine- and 3′ 5′-cyclic adenosine monophosphate- regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid glandJournal of Endocrinological Investigation, 1991
- Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.Proceedings of the National Academy of Sciences, 1991
- Lithium decreases Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortexEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis studyBrain Research, 1991
- Inhibition by dopamine of (Na+ + K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergismNature, 1990
- Neural and developmental actions of lithium: A unifying hypothesisCell, 1989
- Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortexNature, 1988
- Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32Trends in Neurosciences, 1987